6 120 with the four siRNA sequences at different final concentrations using DharmaFECT 121 Transfection Reagent 1 (Dharmacon) or jetPEI (Polyplus) in antibiotic-free media, 122 following the manufacturer's instructions. jetPEI transfection was developed using a 123 ratio of reagent:siRNA of 2:1. The senses of the STAT6 siRNA sequences were:
124 Sequence 1 (STAT6.1): 5' GCAGGAAGAACUCAAGUUUUUUU 3', Sequence 2 125 (STAT6.2): 5' ACAGUACGUUACUAGCCUUUUUU 3', Sequence 3 (STAT6. 280 The cells were cultured for a total of 15 days. The results showed that STAT6.1 and 281 STAT6.4 individually achieved less than approximately 30% reduction of the number 282 of live cells, while the serial combination achieved more than a 30% reduction, 283 regardless of the combination used (Fig 5A and B) . These data confirm that serial 284 injections in animal models could be effective extending the effects of the siRNA 285 sequences. 306 individually at 100 nM had significant effects on cell proliferation and apoptosis of HT-307 29 cells, the efficacy of these STAT6 siRNA sequences was tested using a transfection 308 reagent with proven efficacy in vivo. jetPEI reagent is a linear polyethylenimine 309 derivative, free of components of animal origin, providing a highly effective and 310 reproducible gene delivery to adherent and suspension cells and with a similar 311 composition to in vivo-jetPEI, which is widely use in in vivo studies. In this case, only 312 STAT6.1 was tested. Results using jetPEI for transfection showed again that STAT6.1 313 signifcantly silenced STAT6 expression, obtaining approximately 80% and 314 approximately 50% knockdown at the mRNA and protein levels, respectively, 315 compared with NT cells (Fig 5A and B) . Fig 5C shows how STAT6 fluorescence was 
